Assignee
Fred Hutchison Cancer Center
US·0 granted patents·9 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
9 records- 0172US2025188191A1Compositions and methods to modify cells for therapeutic objectivesFred Hutchison Cancer Center·Filed 2025·Application pending·0 cites
- 0270US2025034250A1Anti-cd33 antibodies and uses thereofFred Hutchison Cancer Center·Filed 2024·Application pending·0 cites
- 0359US2025166723A1Machine learning applications to predict biological outcomes and elucidate underlying biological mechanismsFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
- 0458US2025249125A1Anti-cd90 antibodies, binding fragments, and uses thereofFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
- 0557US2025326856A1Humanized anti-cd45 antibodies and uses thereofFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
- 0657US2025109444A1Dna hypomethylation as a predictive marker for cancer therapyFred Hutchison Cancer Center·Filed 2024·Application pending·0 cites
- 0756US2025034245A1Siglec-8 antibodies and uses thereofFred Hutchison Cancer Center·Filed 2024·Application pending·0 cites
- 0849US2025057840A1Compositions and methods for the treatment of diseases with isocitrate dehydrogenase 1/2 mutationsFred Hutchison Cancer Center·Filed 2024·Application pending·0 cites
- 0943US2025304657A1Antibodies with novel fc modification combinations that increase antibody functionFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fred Hutchison Cancer Center files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →